Orchestra BioMed Holdings, Inc. (OBIO)

NASDAQ: OBIO · USD

$5.99

+0.21 (+3.6%)· Recorded snapshot

Market cap	360M
Revenue (ttm)	32M
Net income (ttm)	-59.6M
EPS (ttm)	-$1.00
Shares out	60.1M
Volume	376,404
Beta	0.52

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 32M
Net income (ttm): -59.6M
EPS (ttm): -$1.00
Market cap: 360M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-397.3

P25 n/aP50 n/aP75 n/a

ROIC-62

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All OBIO indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001814114
Company name	Orchestra BioMed Holdings, Inc.
Country	United States
Country code	US
CUSIP number	68572M106
Earnings date	2026-11-09
Earnings time	amc
Employees	86
Employees change	16
Employees growth	22.86%
Enterprise value	$320.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US68572M1062
Last 10-K release date	2026-03-12
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$360M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$5.99
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	OBIO
U.S. state	Pennsylvania
Website	https://www.orchestrabiomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-16.69%
EV/Sales	10.04x
FCF / EV yield	-18.4%
FCF yield	-16.4%
Forward EV/Sales	737.76x
Forward P/S	827.83x
P/B ratio	17.98x
P/S ratio	11.27x
Price / tangible book value	18.65x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-181.36%
EBITDA margin	-180.27%
Gross margin	99.51%
Operating margin	-181.36%
Pretax margin	-184.6%
Profit margin	-184.6%
Profit per employee	$-692,698
Revenue per employee	$371,814
ROA	-45.73%
ROA (5Y)	-40.95%
ROCE	-56.73%
ROE	-397.3%
ROIC	-62.05%
SBC / revenue	34.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	1
Gross profit growth	1,066.39%
Gross profit growth (Q)	-92.03%
Gross profit growth 3Y	97.38%
Net income growth years	1
Revenue growth	986.14%
Revenue growth (Q)	-89.47%
Revenue growth (QoQ)	-20%
Revenue growth 3Y	94.51%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-781,000
Depreciation and amortization	$349,000
EBIT	$-58M
EBITDA	$-57.6M
EPS	$-1.00
FCF per share	$-0.98
Financing cash flow	$129.3M
Free cash flow	$-59.1M
Free cash flow minus SBC	$-70.2M
Gross profit	$31.8M
Investing cash flow	$-69.3M
Net borrowing	$55M
Net cash flow	$1.7M
Net income	$-59.6M
Operating cash flow minus SBC	$-69.4M
Operating income	$-58M
Revenue	$32M
Stock-based compensation	$11.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.83
Book value per share	$0.32
Debt / equity	2.41
Interest coverage	-10.56
Long-term assets	$4.5M
Long-term liabilities	$72.8M
Net cash (debt)	$39.2M
Net cash / market cap	10.88%
Net cash growth	123.12%
Net debt / equity	-1.33
Piotroski F-Score	4
Property, plant and equipment	$3.2M
Shareholders' equity	$29.4M
Tangible book value	$19.3M
Tangible book value per share	$0.32
Total assets	$115.7M
Total cash	$110M
Total debt	$70.8M
Total liabilities	$86.3M
WACC	6.93%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.4
Current assets	$111.2M
Current liabilities	$13.5M
Current ratio	8.26
Inventory turnover	0.72
Net working capital	$-11.4M
Quick ratio	8.17
Working capital	$97.8M
Working capital turnover	0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-56.5%
Dividend yield	0%
Shareholder yield	-56.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$4.62
1D price change	3.63%
1M price change	0.67%
1M total return	0.67%
1W price change	3.19%
1W total return	3.19%
1Y price change	51.65%
1Y return CAGR	51.69%
1Y total return	51.65%
20-day SMA	$5.78
200-day SMA	$4.52
3M price change	56.81%
3M total return	56.81%
3Y price change	29.94%
3Y return CAGR	9.12%
3Y total return	29.94%
50-day SMA	$5.68
50-day SMA vs 200-day SMA	50over200
52-week high	$6.50
52-week high date	2026-10-01
52-week low	$3.46
52-week low date	2026-01-30
5Y price change	-39.19%
5Y return CAGR	-9.47%
5Y total return	-39.19%
6M price change	46.1%
6M total return	46.1%
All-time high	$23.39
All-time high date	2023-04-03
All-time low	$2.20
All-time low date	2025-09-24
Average true range (ATR)	$0.33
Average volume	337.9K
Beta (1Y)	0.46
Beta (2Y)	1.74
Beta (5Y)	0.52
Change from 52-week high	-7.85%
Change from 52-week low	73.12%
Change from all-time high	-74.39%
Change from all-time low	172.27%
Change from open	3.28%
Day's gap	0.35%
Dollar volume	$2.3M
High price	$6.01
Low price	$5.76
Monthly RSI	55.18
Open price	$5.80
Position in 52-week range	92%
Premarket change	2.08%
Premarket close	$5.78
Premarket price	$5.90
Previous close	$5.78
Price vs 150-day SMA	29.65%
Price vs 20-day SMA	3.62%
Price vs 200-day SMA	32.58%
Price vs 50-day SMA	5.4%
Relative volume	1.13
RSI	56.33
Sharpe ratio	0.9
Sharpe ratio (3Y)	0.47
Sharpe ratio (5Y)	0.28
Sortino ratio	1.62
Sortino ratio (3Y)	0.83
Sortino ratio (5Y)	0.53
Volume	376.4K
Weekly RSI	64.47
YTD price change	44.34%
YTD total return	44.34%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33M
Float percentage	54.84%
Shares change (QoQ)	1.74%
Shares change (YoY)	56.5%
Shares held by insiders	4.11%
Shares held by institutions	26.85%
Shares outstanding	60.1M
Short % of float	7.73%
Short % of shares	4.24%
Short ratio	7 days

Deeper analysis on OBIO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OBIO report

Is a complete OBIO research report available?

No complete published report is available for Orchestra BioMed Holdings, Inc. (OBIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Orchestra BioMed Holdings, Inc. (OBIO)

Price

Financial snapshot

Fair-value bridge

Latest news · OBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OBIO

Frequently asked questions